Climacteric

Article	Citations
Peer reviewers for Climacteric in 2024	119
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study	70
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted	46
Safety and acceptability of intravaginal rings releasing estradiol and progesterone	45
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health	41
Effects of jazz dance and concurrent training on physical variables in postmenopausal women	40
Low thrombin generation in postmenopausal women using estetrol	33
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study	33
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women	32
Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers	29
Peer reviewers for Climacteric in 2022	29
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy	25
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia	25
Women’s experience and management of cognition during menopause transition: a qualitative study	25
The musculoskeletal syndrome of menopause	23
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)	23
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China	21
Quo vadis?	20
‘Menopausando’: a digital health education platform for women in the transition to menopause and postmenopause	19
Treatment, perceptions and burden of vasomotor symptoms among midlife women in Japan	18
Good night and good luck	18
Does climacteric status impact regulation of the autonomic nervous system at the age of 46 years?	17
Comparison of predicted aerobic capacity to measured aerobic capacity in menopausal women: an analysis of three methods	17
Menopausal symptoms among perimenopausal women in rural Turkey: a cross-sectional study	16
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stages	16

Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women	15
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?	15
Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis	15
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis	15
A bibliometric analysis of primary ovarian insufficiency from 2010 to 2020	14
Ellen Theresia Maria Laan (April 3, 1962–January 22, 2022)	14
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA	14
Not just sex: other roles for testosterone in women	13
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause	13
VDRgeneApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies	13
What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review	13
The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece	13
Thank you	12
NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing – a pilot study	12
Progesterone and not estrogens or androgens causes breast cancer	12
Practices and challenges in the management of the menopause in the Asia-Pacific Menopause Federation	12
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index	12
Understanding experiences and views of the menopause in Zimbabwe and South Africa: a qualitative study	12
Reproductive milestones across the lifespan and cardiovascular disease risk in women	11
Factors influencing seogeulpeum among middle-aged Korean women	11
The next chapter	11
Adjuvant treatment with tamoxifen for estrogen receptor-positive breast cancer and gynecological risks in premenopausal and perimenopausal women – a systematic review	10
Postmenopausal women’s adherence to pelvic floor muscle exercises over 2 years	10
Is the patients’ fear of cancer the main barrier to prescribing menopausal hormone therapy?	10
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey	10
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion	10
COVID-19-related premature ovarian insufficiency: case report and literature review	10
Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review	9
Neuroprotective effect of hormone replacement therapy: a review of the literature	9
POESIT recommendations on management of body-identical hormones in menopausal symptoms	9
Impact of overweight and obesity in postmenopausal women	9
Management of menopause: a survey of physicians from the Middle East and Africa	9
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk	9
Management of obesity in menopause	9
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women	9
Menopause hormone treatment after cancer	9
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis	9
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study	8
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice	8
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda	8
The yin and yang of GSM and low sexual desire	8
Premature ovarian insufficiency: addressing the most controversial issues	8
Corneal thickness, contrast sensitivity and binocular vision in menopausal and non-menopausal women	8
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss	8
The association between day-to-day impact of vaginal aging and female sexual function	8
In search of a well-balanced narrative of the menopause momentum	8
Testosterone for women: certainties and uncertainties	7
Effect of hormone therapy on personality traits: preliminary evidence in older men and women	7
REDLINC: two decades of collaborative insights into menopause and women’s health in Latin America	7
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency	7

The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition	7
Is it possible that menopause is associated with telomere length? Findings of an integrative review	7
Psychosomatic and medical experiences of menopause in Chinese women: a social media study	7
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study	7
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause	6
Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age	6
Pulmonary embolism in menopausal hormone therapy: a population-based register study	6
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial	6
IMS World Congress on Menopause	6
Sleep disorders and menopausal symptoms: a Latin American perspective on postmenopausal health	6
Prevalence of depressive symptoms during the menopausal transition in Türkiye: impact of symptom severity, aging anxiety and health-related quality of life	6
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis	6
Endocrine consequences of breast cancer therapy and survivorship	6
The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions	6
Medical management of obesity: unlocking the potential	6
Peer reviewers for Climacteric in 2023	6
Menopausal hormone therapy and coronary heart disease: the roller-coaster history	5
Impacts of menopause hormone therapy on mood disorders among postmenopausal women	5
Updated premature ovarian insufficiency guideline	5
Effect of resistance training combined with β-glucan ingestion on bone of ovariectomized mice	5
Resistance training effects on healthy postmenopausal women: a systematic review with meta-analysis	5
Genitourinary syndrome of menopause: a multicenter study from the Indian Midlife Registry	5
Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition	5
The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals	5
Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study	5
Increasing climacteric symptoms in untreated perimenopausal Finnish women: a 10-year cohort study	5
Analysis of multimorbidity patterns in perimenopausal women based on medical examination data	5
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors	5
Menopause in low and middle-income countries: a scoping review of knowledge, symptoms and management	5
Heart matters: the unique landscape of cardiovascular health in women	5
Gender-affirming hormone therapy and cardiovascular health in transgender adults	5
The effects of hormone replacement therapy on the microbiomes of postmenopausal women	5
BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians’ recommendations	5
Methodological considerations on insulin resistance and osteoporosis in postmenopausal women	5
The prevalence and severity of vasomotor and sexual symptoms among refugee women in Australia	5
Correction	4
Ischemia but no obstructive coronary artery disease: more than meets the eye	4
Use of an estradiol transdermal spray in women with menopausal symptoms: a non-interventional study	4
Transgender health and the impact of aging and menopause	4
Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy?	4
Statement of Retraction: Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial	4
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view	4
Translation and validation of the Depression Anxiety Stress Scales for menopausal women in Indonesia	4
Impact of vaginal estriol on serum hormone levels: a systematic review	4
Unraveling sleep quality in menopausal women: objective assessments and self-reported experiences – a mini-review	4
Treatment patterns of menopausal hormone therapy in South Korea: a nationwide cohort study	4
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy	4
Menopause and aging in sub-Saharan Africa: a narrative review	4
Authorization of anastrazole to prevent breast cancer in postmenopausal women: a bad idea	4
Effects of age of menarche and menopause on mental health in postmenopausal women: a cross-sectional survey	4
Ovarian tissue cryopreservation and transplantation – first baby in China	4
Challenges in setting up menopause care clinics in the Philippines	3
From waste to wellness – what women want: insights into patient perspectives on topical vaginal estrogen applicators and environmental considerations	3
Evidence-based guideline: premature ovarian insufficiency † ‡	3
An interprofessional clinic for adults with Turner syndrome: the patient perspective	3
Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex	3
Urologic view in the management of genitourinary syndrome of menopause	3
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies	3
The rs2018736 fibulin-5 polymorphism as a determinant for pelvic organ prolapse: a case–control study	3
Obesity indices and cardiometabolic diseases in postmenopausal women in Ilorin, Nigeria	3
Menopause and diabetes	3
The WHO claims estrogens are ‘carcinogenic’: is this true?	3
Osteo-sarcopenic obesity in midlife and older women: a current worldwide public health challenge	3
Clinical practice: guidelines, position statements, recommendations and tool kits	3
Cardiovascular disease in women: take it to heart	3
Fezolinetant for VMS: a balanced view on efficacy and safety needed	3
Polycystic ovary syndrome: associations with cardiovascular disease	3
Complementary therapies for women with premature ovarian insufficiency: a systematic literature review to inform the 2024 update of the ESHRE/ASRM/IMS/CRE-WHiRL guidelines on premature ovarian insuffi	3
Flaxseed and mulberry extract improve trabecular bone quality in estrogen-deficient rats	3
Non-hormonal treatments for managing vulvovaginal atrophy/genitourinary syndrome of menopause	3
Testosterone and the heart: friend or foe?	2
Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis	2
Effect of hormone therapy on tryptophan metabolism and atherosclerosis among postmenopausal women	2
Factors associated with the age of natural menopause in the ELSA-Brasil cohort	2
Understanding of and clinical approach to cardiometabolic transition at the menopause	2
Perimenopausal combined hormonal contraception: focus on sexual function	2
Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study	2
Correction	2
Sequential treatment in vulvovaginal atrophy	2
Effects of a therapeutic lifestyle modification intervention on health-related quality of life and sexual functioning and cardiometabolic health in perimenopausal Chinese women: a randomized controlle	2

Treatment of women with BRCA mutation	2
Arthralgia in midlife Singaporean women: the Integrated Women’s Health Program (IWHP)	2
Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser	2
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial [Letter]	2
The impact of micronized progesterone on cardiovascular events – a systematic review	2
Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS)	2
The effects of repeat fractional CO 2 laser for postmenopausal vaginal symptoms following unblinding from a double-blind RCT	2
Presidential reflections: how we got here, where we might go	2
Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women	2
Associations between blood sex hormones, cognitive decline and incident dementia in community-dwelling older Australian women: a prospective cohort study	2
Comparison of bone mineral density and influencing factors in iatrogenic and idiopathic POI	2
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis	2
Alterations of regional homogeneity in perimenopause: a resting-state functional MRI study	2
Correction	2
Bone health 2022: an update	2
Simulation-based model of menopause: hormonal changes and cardiovascular risk in a digital twin view	2
Telemedicine and women’s health	2
The influence of HIV on body composition and its relationship with physical function in mid-life women: a cross-sectional study from Zimbabwe	2
Fezolinetant for VMS: a balanced view on efficacy and safety needed – author’s reply	2
Physician–patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe	2
Healthy aging in midlife and menopausal transition in Asia: nutrient synergy with dietary supplements	2